US Patent 8673939 Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
Patent 8673939 was granted and assigned to Celgene on March, 2014 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 1, 2013
0
Date of Patent
March 18, 2014
0
Patent Applicant
Patent Application Number
13782728
0
Patent Citations Received
Patent Inventor Names
Jerome B. Zeldis
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8673939 Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
